Results 251 to 260 of about 170,756 (308)
In silico design of blue laser soft tissue vaporization with optimized optical power efficiency and mitigated thermal side effects. [PDF]
Nishimura T +4 more
europepmc +1 more source
In Silico Design, Optimization, and Evaluation of a Multi-Epitope Vaccine Targeting the <i>Clostridium perfringens</i> Collagen Adhesin Protein. [PDF]
Chundru D +6 more
europepmc +1 more source
In Silico Design and Characterization of a Multiepitope Vaccine Candidate Against <i>Brucella canis</i> Using a Reverse Vaccinology Approach. [PDF]
Arriagada V +14 more
europepmc +1 more source
In Silico Design of Antimicrobial Peptides
The rapid spread of drug-resistant pathogenic microbial strains has created an urgent need for the development of new anti-infective molecules, having different mechanism of action in comparison to existing drugs. Natural antimicrobial peptides (AMPs) represent a novel class of molecules with a broad spectrum of activity and a low rate in inducing ...
Maccari Giuseppe +2 more
openaire +5 more sources
In silico design of foldable lasso peptides [PDF]
Lasso peptides are a unique class of natural products with distinctively threaded structures, conferring exceptional stability against thermal and proteolytic degradation. Despite their promising biotechnological and pharmaceutical applications, reported attempts to prepare them by chemical synthesis result in forming the nonthreaded branched-cyclic ...
John D.M. Nguyen +4 more
openaire +3 more sources
Methods and Applications of In Silico Aptamer Design and Modeling
Aptamers are nucleic acid analogues of antibodies with high affinity to different targets, such as cells, viruses, proteins, inorganic materials, and coenzymes. Empirical approaches allow the design of in vitro aptamers that bind particularly to a target
Andrey A Buglak +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fragment-to-lead tailored in silico design
Drug Discovery Today: Technologies, 2021Fragment-based drug discovery (FBDD) emerged as a disruptive technology and became established during the last two decades. Its rationality and low entry costs make it appealing, and the numerous examples of approved drugs discovered through FBDD validate the approach. However, FBDD still faces numerous challenges. Perhaps the most important one is the
Moira Rachman +3 more
openaire +2 more sources
In Silico Design of Anticancer Peptides
2017In the past few years, small peptides having anticancer properties have emerged as a potential avenue for cancer therapy. Compared to current anti-cancer chemotherapeutic drugs (or small molecules), anticancer peptides (ACPs) have numerous advantageous properties, such as high specificity, low production cost, high tumor penetration, ease of synthesis ...
Shailesh, Kumar, Hui, Li
openaire +2 more sources

